159 related articles for article (PubMed ID: 32077346)
1. Role of p38-mitogen-activated protein kinase in COPD: pathobiological implications and therapeutic perspectives.
Pelaia C; Vatrella A; Sciacqua A; Terracciano R; Pelaia G
Expert Rev Respir Med; 2020 May; 14(5):485-491. PubMed ID: 32077346
[No Abstract] [Full Text] [Related]
2. Role of p38 Mitogen-Activated Protein Kinase in Asthma and COPD: Pathogenic Aspects and Potential Targeted Therapies.
Pelaia C; Vatrella A; Gallelli L; Lombardo N; Sciacqua A; Savino R; Pelaia G
Drug Des Devel Ther; 2021; 15():1275-1284. PubMed ID: 33790539
[TBL] [Abstract][Full Text] [Related]
3. The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial.
Patel NR; Cunoosamy DM; Fagerås M; Taib Z; Asimus S; Hegelund-Myrbäck T; Lundin S; Pardali K; Kurian N; Ersdal E; Kristensson C; Korsback K; Palmér R; Brown MN; Greenaway S; Siew L; Clarke GW; Rennard SI; Make BJ; Wise RA; Jansson P
Int J Chron Obstruct Pulmon Dis; 2018; 13():1009-1019. PubMed ID: 29628759
[TBL] [Abstract][Full Text] [Related]
4. p38 mitogen-activated protein kinase pathways in asthma and COPD.
Chung KF
Chest; 2011 Jun; 139(6):1470-1479. PubMed ID: 21652557
[TBL] [Abstract][Full Text] [Related]
5. Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungs.
Gaffey K; Reynolds S; Plumb J; Kaur M; Singh D
Eur Respir J; 2013 Jul; 42(1):28-41. PubMed ID: 23060629
[TBL] [Abstract][Full Text] [Related]
6. Increased activation of p38 MAPK in COPD.
Renda T; Baraldo S; Pelaia G; Bazzan E; Turato G; Papi A; Maestrelli P; Maselli R; Vatrella A; Fabbri LM; Zuin R; Marsico SA; Saetta M
Eur Respir J; 2008 Jan; 31(1):62-9. PubMed ID: 17959643
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal administration of antisense oligonucleotide against p38α but not p38β MAP kinase isoform reduces neuropathic and postoperative pain and TLR4-induced pain in male mice.
Luo X; Fitzsimmons B; Mohan A; Zhang L; Terrando N; Kordasiewicz H; Ji RR
Brain Behav Immun; 2018 Aug; 72():34-44. PubMed ID: 29128611
[TBL] [Abstract][Full Text] [Related]
8. Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium.
Vallese D; Ricciardolo FL; Gnemmi I; Casolari P; Brun P; Sorbello V; Capelli A; Cappello F; Cavallesco GN; Papi A; Chung KF; Balbi B; Adcock IM; Caramori G; Di Stefano A
Respiration; 2015; 89(4):329-42. PubMed ID: 25791156
[TBL] [Abstract][Full Text] [Related]
9. p38alpha-selective mitogen-activated protein kinase inhibitor SD-282 reduces inflammation in a subchronic model of tobacco smoke-induced airway inflammation.
Medicherla S; Fitzgerald MF; Spicer D; Woodman P; Ma JY; Kapoun AM; Chakravarty S; Dugar S; Protter AA; Higgins LS
J Pharmacol Exp Ther; 2008 Mar; 324(3):921-9. PubMed ID: 18056868
[TBL] [Abstract][Full Text] [Related]
10. Sex-specific control of central nervous system autoimmunity by p38 mitogen-activated protein kinase signaling in myeloid cells.
Krementsov DN; Noubade R; Dragon JA; Otsu K; Rincon M; Teuscher C
Ann Neurol; 2014 Jan; 75(1):50-66. PubMed ID: 24027119
[TBL] [Abstract][Full Text] [Related]
11. Opposing Oncogenic Functions of p38 Mitogen-activated Protein Kinase Alpha and Beta in Human Pancreatic Cancer Cells.
Tian X; Traub B; Xie X; Zhou S; Henne-Bruns D; Knippschild U; Kornmann M
Anticancer Res; 2020 Oct; 40(10):5545-5556. PubMed ID: 32988878
[TBL] [Abstract][Full Text] [Related]
12. Activity of sputum p38 MAPK is correlated with airway inflammation and reduced FEV1 in COPD patients.
Huang C; Xie M; He X; Gao H
Med Sci Monit; 2013 Dec; 19():1229-35. PubMed ID: 24382347
[TBL] [Abstract][Full Text] [Related]
13. Differential Modulation of the Phosphoproteome by the MAP Kinases Isoforms p38α and p38β.
Melamed Kadosh D; Beenstock J; Engelberg D; Admon A
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569817
[TBL] [Abstract][Full Text] [Related]
14. Protective Effect of Hydroxysafflor Yellow A on Inflammatory Injury in Chronic Obstructive Pulmonary Disease Rats.
Jin M; Xue CJ; Wang Y; Dong F; Peng YY; Zhang YD; Zang BX; Tan L
Chin J Integr Med; 2019 Oct; 25(10):750-756. PubMed ID: 30588579
[TBL] [Abstract][Full Text] [Related]
15. Differential tissue expression and activation of p38 MAPK alpha, beta, gamma, and delta isoforms in rheumatoid arthritis.
Korb A; Tohidast-Akrad M; Cetin E; Axmann R; Smolen J; Schett G
Arthritis Rheum; 2006 Sep; 54(9):2745-56. PubMed ID: 16947383
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases.
Chopra P; Kanoje V; Semwal A; Ray A
Expert Opin Investig Drugs; 2008 Oct; 17(10):1411-25. PubMed ID: 18808304
[TBL] [Abstract][Full Text] [Related]
17. Differential expression and activation of p38 mitogen-activated protein kinase alpha, beta, gamma, and delta in inflammatory cell lineages.
Hale KK; Trollinger D; Rihanek M; Manthey CL
J Immunol; 1999 Apr; 162(7):4246-52. PubMed ID: 10201954
[TBL] [Abstract][Full Text] [Related]
18. Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils.
Nick JA; Avdi NJ; Young SK; Lehman LA; McDonald PP; Frasch SC; Billstrom MA; Henson PM; Johnson GL; Worthen GS
J Clin Invest; 1999 Mar; 103(6):851-8. PubMed ID: 10079106
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors and Activators of the p38 Mitogen-Activated MAP Kinase (MAPK) Family as Drugs to Treat Cancer and Inflammation.
Denny WA
Curr Cancer Drug Targets; 2022; 22(3):209-220. PubMed ID: 35168519
[TBL] [Abstract][Full Text] [Related]
20. Investigational p38 inhibitors for the treatment of chronic obstructive pulmonary disease.
Norman P
Expert Opin Investig Drugs; 2015 Mar; 24(3):383-92. PubMed ID: 25599809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
